ABSTRACT. Biosynthesis of three major peroxisomal membrane polypeptides (70, 26, and 22 kD) were investigated in an attempt to account for the absence of peroxisomes in patients with Zellweger syndrome. Immunoblot analysis using membrane fractions of autopsied livers revealed that 70-and 22-kD polypeptides were deficient in three Japanese patients with this syndrome. However, pulse-labeling and chase experiments using cultured skin fibroblasts demonstrated that 70-, 26, and 22-kD polypeptides were synthesized in these patients at levels similar to those in the controls. No significant difference in the degradation rates of these polypeptides was noted between the patients and the controls. Subcellular fractionation after pulse-chase experiments revealed 70-kD polypeptides present in a membrane fraction of the cells. These observations indicate that at least 70-, 26-, and 22-kD peroxisomal membrane polypeptides are normally synthesized and considered to be transported into the disorganized peroxisomal membrane in patients with Zellweger syndrome. Molecular and functional analyses of these polypeptides are underway to clarify whether they contribute to membrane integrity or to the transport of peroxisomal matrix enzymes. The cerebro-hepato-renal syndrome of Zellweger (McKusick 2 14 10) is a fatal autosomal recessive disease, with clinical findings including severe neurologic abnormalities, dysmorphic features, hepatomegaly and multiple renal cysts (1). This disorder is characterized by the absence of peroxisomes (2) and regarded as a prototype of peroxisomal disorders such as neonatal adrenoleukodystrophy, infantile Refsum's disease, rhizomelic chondrodysplasia punctata, hyperpipecolic acidemia (3), and Zellwegerlike syndrome (4). Although a number of metabolic defects, including @-oxidation system (4-6), plasmalogen biosynthesis (7, 8), phytanic acid oxidation (9), and pipecolic acid oxidation (10) have been linked to Zellweger syndrome, the primary etiology of this syndrome is still unknown. Multiple deficiencies of peroxisoma1 enzymes are considered to be caused by failure of localization into peroxisomes and by a secondary degradation once they are synthesized, presumably caused by a defect in biogenesis of the normal peroxisomes.
IMP, integral membrane polypeptide MEM, minimal essential medium
The cerebro-hepato-renal syndrome of Zellweger (McKusick 2 14 10) is a fatal autosomal recessive disease, with clinical findings including severe neurologic abnormalities, dysmorphic features, hepatomegaly and multiple renal cysts (1) . This disorder is characterized by the absence of peroxisomes (2) and regarded as a prototype of peroxisomal disorders such as neonatal adrenoleukodystrophy, infantile Refsum's disease, rhizomelic chondrodysplasia punctata, hyperpipecolic acidemia (3), and Zellwegerlike syndrome (4) . Although a number of metabolic defects, including @-oxidation system (4-6), plasmalogen biosynthesis (7, 8) , phytanic acid oxidation (9) , and pipecolic acid oxidation (10) have been linked to Zellweger syndrome, the primary etiology of this syndrome is still unknown. Multiple deficiencies of peroxisoma1 enzymes are considered to be caused by failure of localization into peroxisomes and by a secondary degradation once they are synthesized, presumably caused by a defect in biogenesis of the normal peroxisomes.
There are at least two hypotheses regarding the biogenesis of peroxisomes. The classical model of budding theory, in which peroxisomes are formed by budding from the endoplasmic reticulum (1 I), has been challenged by a new model in which new peroxisomes are formed from preexisting ones (12) . The latter theory is supported by findings that both matrix enzymes (13) and IMP of peroxisomes (14, 15) are synthesized on free polysomes and are subsequently localized in the organelle. IMP are considered to have important roles for the integrity of the membrane, localization of matrix enzymes, and transport of metabolites.
Recently, an abnormality of an IMP of peroxisomes was postulated for the primary etiology of Zellweger syndrome and neonatal adrenoleukodystrophy (1 6). Lazarow et al. (1 7) reported that 22-kD IMP of peroxisomes and peroxisomal membrane ghosts (18) are present in patients with Zellweger syndrome. We previously reported that 70-kD IMP was synthesized in a patient with this syndrome (19) . In this report, we investigated the biosynthesis and intracellular localization of three major IMP (70, 26, and 22 kD) in three Japanese patients with Zellweger syndrome to evaluate more precisely the roles of these IMP for the etiology of this syndrome.
MATERIALS AND METHODS
Three control patients with conditions not associated with known peroxisomal diseases and three patients with Zellweger syndrome were investigated. All Zellweger patients were Japanese and typical findings including accumulation of very long-chain fatty acids, absent peroxisomal enzymes and undetectable peroxisomes were found. They died within several months after birth and autopsied organs were stored at -80°C until use.
Immunoblotting. Membrane fractions of liver tissues were obtained according to the method of Fujiki et al. (20) with slight modifications. The liver (0.5 g) was homogenized with 5 mL of 0.1 M potassium phosphate buffer, pH 8, and centrifuged for 45 min at 40000 rpm (140000 x g ) (Hitachi model 70P-72, Hitachi Koki, Katsuta, Japan). The precipitate was homogenized with 5 mL of 0.1 M Na2C03, cooled on ice for 30 min and recentrifuged for 45 min at 40000 mm. brane polypeptides were located on the sheet using anti-70-, 26-, and 22-kD IMP of rat liver peroxisomes and goat antirabbit IgG, horseradish peroxidase conjugate (Bio-Rad, Watford, England). Purification of rat peroxisomal membrane polypeptides and preparation of antibodies were performed according to Hashimoto et al. (23) . Cross-reactivity of these antibodies against rat enzymes to human subjects was confirmed in previous report (1 9).
Pulse-chase experiments of fibroblasts. Skin fibroblasts from two controls and two patients with Zellweger syndrome were cultivated in Eagle's MEM (Nissui, Tokyo, Japan) supplemented with 10% FCS (GIBCO, Grand Island, NY) in 20 cm2 dishes. At the time of confluency, the cells in each dish were preincubated with 5 ml of MEM free of methionine for 1 h, then the medium was replaced with fresh methionine-free medium (1 mL) supplemented with 0.5 mCi of [35S]methionine (>I000 Ci/mmol, Amersham, Buckinghamshire, England). The cells were cultivated for 2 h in the labeled medium (pulse labeling) then were harvested immediately after labeling, or chased for 6 or 24 h with fresh MEM supplemented with methionine. The harvested cells were suspended in 0.5 mL of immunoprecipitation buffer (10 mM Tris-HC1, pH 7.412 mM EDTAIO. 1 % SDSIO. 1 % Triton X-100/10 mM methioninelo. 1 % BSAIIO pg/mL of protease inhibitors), frozen and thawed three times, sonicated for 30 s, and centrifuged. Supernatants were immunoprecipitated with anti-70-, 26-, and 22-kD IMP and then subjected to SDSIPAGE and fluorography as described (24) .
Subcellular distribution of the radiolabeled IMP in the fibroblasts was investigated as follows. Fibroblasts pulse labeled or chased as mentioned above were suspended in 0.5 mL of buffer consisting 10 mM Tris-HC1, pH 7.412 mM EDTAIIO mM methioninelo. 1 % BSA, frozen and thawed, sonicated, and centrifuged for 45 min at 40000 rpm. The supernatant was immediately immunoprecipitated. The pellet was resuspended with 0.5 mL of immunoprecipitation buffer, sonicated, immunoprecipitated and subjected SDSIPAGE, as described above.
RESULTS
Immunoblot analysis. Immunoblot analysis of peroxisomal IMP, using the membrane fractions of liver tissues revealed that the 70-kD IMP was scanty in all three patients with Zellweger syndrome (Fig. IA, lanes 4, 5, and 6 ), whereas this IMP was clearly detected in the controls (lanes 2, 3, and 7) and from a rat (lane 8). The 22-kD IMP was detected in two of the three patients ( Fig. 1 B, lanes 4 and 5 ) and in all of the controls (lanes 4,5, and 6). However, the amount of the 22-kD IMP in these patients was far less than that in the controls and it was not detected in one patient (lane 6). This polypeptide was soon undetectable when the sample of the patient was stored at -20°C for a long time or in case of several freezings and thawings (data not shown). The 26-kD IMP was hardly detectable in human tissues by the method we used.
Pulse-chase experiments offibroblasts. Pulse labeling with I3'S] methionine revealed that the 70-kD IMP was synthesized in fibroblasts from the patients, at a level similar to that seen in the controls ( Fig. 2A, P) . The size of the pulse-labeled precursor polypeptide was identical to that of mature polypeptide in the chase experiment, as in the case of experiments on rats (15) . These bands remained clear by the 6-h chase experiment ( Fig.  2A, 6 ) and became fainter by the 24-h chase ( Fig. 2A, 24 ). There was no significant difference in the degradation rates between tissues from the patients and from the controls.
The radiolabeled 26-kD IMP was detected in tissues from both patients and controls, at a similar level, in the pulse and the chase experiments (Fig. 2B) . A slightly larger band (about 27 kD) was detected in every lane. Because the anti-26-kDa antibody used is known to cross-react with the 27-kD IMP (23) , this larger band may be the 27-kD IMP. The relationship between these two polypeptides remains to be elucidated.
The 22-kD IMP was also synthesized in all cell lines tested (Fig. 2C) . Degradation rate of this polypeptide in tissues from the patients was also similar to that in the controls. The smaller band (about 20 kD) found in tissues from both patients and controls was probably formed by the proteolytic degradation of 22-kD IMP, as described by Fujiki et al. (13) Subcellular localization of IMP synthesized in pulse-chase experiments was also investigated (Fig. 3) . Catalase, one of the matrix enzymes of peroxisomes, was detected in the soluble fraction, but not in the membrane fraction in the control after the cells were sonicated and ultracentrifuged (Fig. 3A) . This was likely due to the destruction of the structure of peroxisomes by ET AL.
-catalase Fig. 3 . Subcellular distribution of radiolabeled 70-kDa IMP. Fibroblasts were pulse-labeled with [35S]methionine, then soluble and membrane fractions were prepared, as described in "Materials and Methods." Catalase ( A ) was detected in the soluble fraction (S), whereas 70-kD IMP (B) was predominantly detected in the membrane fraction (M) in both the patients with Zellweger syndrome (Z) and the controls (C). Heavy background in B was due to insufficient washing after immunoprecipitation. P, pulse labeling for 2 h; 24, chase for 24 h. the sonication. In the patient with Zellweger syndrome, in whom catalase was shown to be present in the cytosol (25) , this enzyme was also detected in the soluble fraction. However, the 70-kD IMP was detected in the membrane fraction and not in the soluble fraction, in tissues from both patients and controls (Fig.  3B) . These results suggest that IMP synthesized in fibroblasts are localized in the disorganized peroxisomal membrane in patients with Zellweger syndrome.
DISCUSSION
Biochemical analyses revealed a number of polypeptides on the membrane of peroxisomes. IMP with M, of 22-, 67.7-, and 69.7-kD were purified by Fujiki et al. (26) . Hashimoto et al. (23) purified 70-, 68-, 41-, 27-, 26-, and 22-kDa IMP and demonstrated their induction with the administration of di(2-ethylhexyl)phthalate, a peroxisomal proliferating agent, in parallel with the enzymes of peroxisomal @-oxidation (23) . IMPS of peroxisomes are synthesized on free polysomes, as in the case of matrix enzymes of peroxisomes (1 5).
These investigations support the hypothesis that peroxisomes are formed by fission from preexisting peroxisomes and suggest that membrane polypeptides play important roles in the biogenesis of peroxisomes, integrity of peroxisomal membrane, transport of metabolites, and localization of peroxisomal matrix enzymes. This suggests the possibility that a defect in a peroxisomal membrane polypeptide might be responsible for the primary etiology of the peroxisome-deficient disorders including Zellweger syndrome, neonatal adrenoleukodystrophy and infantile Refsum's disease. Lazarow et al. (19) reported that the 22-kD polypeptide was present in the membrane fraction of liver tissues from patients with Zellweger syndrome. They speculated that the peroxisomal membranes are assembled in patients with this syndrome, but may be defective for the import of matrix proteins (17) . Small et al. (27) reported the presence of 70-kD (referred to as 69 kD), 53-kD and 22-kD IMP in livers from patients with Zellweger syndrome, infantile Refsum's disease, and X-linked adrenoleukodystrophy (27) .
In our study, we found that the 70-kD polypeptide was deficient in all of three Japanese patients with Zellweger syndrome, and the 22-kD polypeptide was presented in two of three patients, albeit the amount being scanty. The difference between Japanese and American (and Australian) patients may be due to different genetic defects as demonstrated by Brul et al. (28) , or simply due to postmortem change. Pulse-chase experiments of fibroblasts from our patients revealed that at least 70-, 26-, and 22-kD polypeptides were synthesized at levels similar to those in the controls. The 70-kD polypeptide was integrated into the membrane fraction of cells soon after being synthesized on free polysomes in the cytosol; yet the precise location within the membrane was not elucidated. These observations suggest that 70-kD IMP probably localizes in a rudimentary membrane of the peroxisomes in patients with Zellweger syndrome. The other two polypeptides are also probably integrated into the peroxisoma1 membrane although this was not confirmed because of the low sensitivity of our assay. The results also indicate that deficiency of the 70-26-, or 22-kD IMP is not the primary defect in Zellweger syndrome. However, the functions of these IMP, which remain to be elucidated, may be defective in this syndrome. 
